Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003

Inhibition of the activity of poly(ADP-ribose) polymerase in haemorrhagic shock

M. McDonald, H. Mota-Filipe, M. Abdelrahman, M. Threadgill, C. Thiemermann

Med Sci Monit 2003; 9(1): 41-0 :: ID: 15104

Abstract

There is good evidence that haemorrhagic shock is associated with the generation of reactive oxygen species (ROS) including superoxide anions and hydrogen peroxide [1]. It has been suggested that the activation of PARP plays a role in the cardiovascular failure associated with haemorrhagic shock [2], but there is little information regarding the role of PARP in the pathophysiology of the organ dysfunction/injury associated with haemorrhagic shock. Here we investigate the effects of several PARP inhibitors on the circulatory failure and the organ injury and dysfunction caused by severe haemorrhage and resuscitation in the anaesthetised rat. Male Wistar rats were anaesthetised with thiopentone sodium (120 mg/kg i.p.) and instrumented for the measurement of mean arterial pressure and heart rate. Haemorrhage (to lower blood pressure to ~50 mmHg for 90 min) and resuscitation (with blood and an equivalent volume of Ringers Lactate solution), resulted within 4 h in a delayed fall in blood pressure as well as in renal dysfunction, liver injury and dysfunction, pancreatic injury, and neuromuscular injury. Treatment of rats subjected to haemorrhage and resuscitation with the PARP inhibitors 3-aminobenzamide (10 mg/kg), nicotinamide (10 mg/kg), or 1,5 dihydroxyisoquinoline (ISO, 3 mg/kg) attenuated the multiple organ injury and dysfunction caused by haemorrhage and resuscitation. However, treatment with the vehicle for ISO (10% v/v DMSO) had a similar effect. As the beneficial effects of ISO (the most potent and specific PARP inhibitor) were, in part, due to its vehicle, further studies with the potent, specific and water soluble inhibitor of PARP activity, 5-aminoisoquinolinone (5-AIQ), were performed to ensure that the reduction by the agents of the multiple organ failure in haemorrhagic shock is indeed due to their ability to inhibit PARP activity. Administration (5 min prior to resuscitation of 5-AIQ (0.03 mg/kg i.v, or 0.3 mg/kg i.v.) reduced (in a dose-related fashion) the multiple organ injury and dysfunction, but did not affect the circulatory failure, associated with haemorrhagic shock. In conclusion, this study demonstrates that chemically distinct inhibitors of PARP activity attenuate the renal dysfunction, the hepatocellular injury and the pancreatic injury associated with severe haemorrhage and resuscitation. References: 1.Redl H, Gasser H, Schlag G, Marzi I: Involvement of oxygen radicals in shock related cell injury. Br Med Bull, 1993; 49: 556-65 2.Szabo C: Potential role of peroxynitrite-poly (ADP-ribose) synthetase pathway in a rat model of severe hemorrhagic shock. Shock, 1998; 9: 341-344

Keywords: PARP, haemorrhage, multiple organ injury, Shock

Add Comment 0 Comments

Editorial

01 April 2024 : Editorial  

Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug Resistance

Dinah V. Parums

DOI: 10.12659/MSM.944600

Med Sci Monit 2024; 30:e944600

0:00

In Press

06 Mar 2024 : Clinical Research  

Comparison of Outcomes between Single-Level and Double-Level Corpectomy in Thoracolumbar Reconstruction: A ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943797  

21 Mar 2024 : Meta-Analysis  

Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, a...

Med Sci Monit In Press; DOI: 10.12659/MSM.943863  

10 Apr 2024 : Clinical Research  

Predicting Acute Cardiovascular Complications in COVID-19: Insights from a Specialized Cardiac Referral Dep...

Med Sci Monit In Press; DOI: 10.12659/MSM.942612  

06 Mar 2024 : Clinical Research  

Enhanced Surgical Outcomes of Popliteal Cyst Excision: A Retrospective Study Comparing Arthroscopic Debride...

Med Sci Monit In Press; DOI: 10.12659/MSM.941102  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750